SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Blue Jet Healthcare - Quaterly Results

22 Jul 2025 Evaluate
The total revenue stands at Rs. 3547.58 millions for the June 2025 quarter. The mentioned figure indicates an increase of about 117.78% as against Rs. 1628.99 millions during  the year-ago period.Net Profit for the quarter ended June 2025 zoomed to 141.34% from Rs. 377.77 millions to Rs. 911.70  millions.Operating profit for the quarter ended June 2025 rose to 1292.48 millions as compared to 529.78 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 3547.58 1628.99 117.78 3547.58 1628.99 117.78 10299.85 7115.98 44.74
Other Income 82.54 87.15 -5.29 82.54 87.15 -5.29 462.56 288.60 60.28
PBIDT 1292.48 529.78 143.97 1292.48 529.78 143.97 4239.86 2580.90 64.28
Interest 6.90 0.27 2455.56 6.90 0.27 2455.56 0.98 1.61 -39.13
PBDT 1285.58 529.51 142.79 1285.58 529.51 142.79 4238.88 2481.86 70.79
Depreciation 56.98 34.82 63.64 56.98 34.82 63.64 177.89 280.91 -36.67
PBT 1228.60 494.69 148.36 1228.60 494.69 148.36 4060.99 2200.95 84.51
TAX 316.90 116.92 171.04 316.90 116.92 171.04 1008.96 563.44 79.07
Deferred Tax 18.90 19.42 -2.68 18.90 19.42 -2.68 41.21 21.44 92.21
PAT 911.70 377.77 141.34 911.70 377.77 141.34 3052.03 1637.51 86.38
Equity 346.93 346.93 0.00 346.93 346.93 0.00 346.93 346.93 0.00
PBIDTM(%) 36.43 32.52 12.02 36.43 32.52 12.02 41.16 36.27 13.50

Blue Jet Healthcare Share Price

407.30 37.00 (9.99%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×